IMM-H025

N/A

Report date: 2025/03/07 15:29:07
NME

Base Information

Drug NameIMM-H025
Drug Alias NameIMM-H025IMMH025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCluster of differentiation 8 inhibitorsInterferon gamma inhibitorsTumor necrosis factor α inhibitors
TargetsCluster of differentiation 8Interferon gammaTumor necrosis factor α
Therapy Area/IndicationsAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsAnemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A